Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Retina. 2018 Aug;38(8):1443–1455. doi: 10.1097/IAE.0000000000002197

Figure 3.

Figure 3

Therapeutic options for recessive and dominant conditions. (A) Diseases resulting from recessive mutations can be corrected by the addition of a wild-type gene, as in gene therapy. (B) Diseases resulting from dominant mutations cannot be corrected by the addition of a wild-type gene. Correction of the pathogenic dominant mutation by DNA repair, e.g. CRISPR-mediated genome surgery, is needed.